Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.85    0.10 (3.64%)
Bid:
2.75
Ask:
2.85
Spread: 0.10 (3.636%)
Market Cap: £5.20m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Director/PDMR Shareholding

15 May 2018 15:58

RNS Number : 1775O
Nanoco Group PLC
15 May 2018
 

NANOCO GROUP PLC

NOTIFICATION OF TRANSACTIONS BY DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

 

Nanoco Group plc ("Nanoco" or the "Company") announces today that on 14 May 2018, Michael Edelman, Chief Executive Officer disposed of 1,700,000 Ordinary Shares at an average price of 42.2p in order to settle personal commitments and, on 9 May 2018, transferred 150,000 Ordinary Shares into a charitable donor advised fund at a value of 48.98p which subsequently sold the shares at the average price 44.47p. Following this disposal, Michael Edelman holds a beneficial interest of 3,124,350 Ordinary Shares in the Company representing 1.09% of the total issued share capital.

 

1

Details of the person discharging managerial responsibilities / person closely associated

(a)

Name

Michael Edelman

2

Reason for the notification

(a)

Position/status

Director (CEO)

(b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

(a)

Name

Nanoco Group plc

(b)

LEI

213800HOSJEZO1KOCV33

4

Details of the transaction(s)

(a)

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

ISIN: GB00B01JLR99

(b)

Nature of the transaction

Sale of shares

(c)

Price(s) and volume(s)

 

 

 

Date

Price(s)

Volume

Type

14/05/2018

42.0p

1,500,000

sale

14/05/2018

43.7p

200,000

sale

09/05/2018

48.98p

150,000

transfer

14/05/2018

43.0p

20,000

sale

14/05/2018

43.1p

10,000

sale

14/05/2018

43.2p

9,000

sale

14/05/2018

43.25p

21,295

sale

14/05/2018

43.3p

5,000

sale

14/05/2018

43.45p

20,099

sale

14/05/2018

43.65p

9,453

sale

14/05/2018

45.0p

6,058

sale

14/05/2018

45.9p

14,555

sale

14/05/2018

46.35p

5,000

sale

11/05/2018

46.45p

13,133

sale

11/05/2018

47.0p

3,349

sale

11/05/2018

48.0p

5,000

sale

10/05/2018

48.05p

7,293

sale

10/05/2018

48.1p

765

sale

(d)

Aggregated information

· Aggregated volume

Sale volume: 1,850,000 Ordinary shares

Average price: 42.38p

 

(excluding the transfer of 150,000 ordinary shares above)

(e)

Date of the transaction

As above

(f)

Place of the transaction

London Stock Exchange (XLON); Main Market

 

The person responsible for arranging for the release of this announcement on behalf of the Company is David Blain, Chief Financial Officer.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKPDPQBKDPPD
Date   Source Headline
26th Jun 20267:00 amRNSCommencement of Shareholder Consultation
25th Jun 20267:00 amRNSBoard Update
19th Jun 202610:33 amRNSAdjournment of General Meeting
18th Jun 20267:00 amRNSIntention to adjourn General Meeting
9th Jun 20267:00 amRNSGlass Lewis recommendation
5th Jun 202611:55 amRNSTR-1: Notification of major holdings
27th May 20267:00 amRNSIntention to delist from London Stock Exchange
20th Apr 20265:37 pmRNSDirector/PDMR Shareholding
20th Apr 20267:00 amRNSInterim Results
13th Apr 20267:00 amRNSNotice of Results
26th Mar 20267:00 amRNSShoei Litigation Conclusion
19th Mar 20267:00 amRNSStay of Shoei Litigation
23rd Feb 20267:00 amRNSShoei Litigation Update
26th Jan 20267:00 amRNSConclusion of CDX process & Directorate changes
15th Jan 20261:08 pmRNSReceipt of Litigation Proceeds
13th Jan 20264:50 pmRNSResult of AGM
12th Jan 20267:00 amRNSLitigation update
9th Dec 20257:00 amRNSBlocklisting Six-Monthly Return
8th Dec 202511:16 amRNSNotice of AGM
27th Nov 20257:00 amRNSResponse to non-infringement claim
26th Nov 20257:00 amRNSAnnual Report and Accounts
20th Nov 20257:00 amRNSLitigation outcome – Settlement agreed
18th Nov 20257:07 amRNSPreliminary Results
13th Nov 20257:00 amRNSNotice of Results
4th Nov 20257:06 amRNSExtension of Joint Development Agreement
15th Oct 20257:00 amRNS-RAwarding of Government Grant
30th Sep 20254:30 pmRNSTotal Voting Rights and Share Capital
8th Sep 20257:00 amRNSIssue of Equity and Director/PDMR Shareholdings
19th Aug 20257:00 amRNSFull Year Trading Update & Director Retirement
9th Jun 20257:00 amRNSBLOCKLISTING SIX-MONTHLY RETURN
28th Apr 202510:48 amRNSJoint Development Agreement
25th Apr 20257:00 amRNSPatent infringement lawsuit against LG
17th Apr 20253:54 pmRNSHigh Court Confirmation of Capital Reduction
15th Apr 20257:00 amRNSInterim Results & Investor Presentation
13th Mar 20257:00 amRNSNotice of Results
21st Jan 20252:20 pmRNSAnnual General Meeting – Voting Results
18th Dec 20248:26 amRNSDirector/PDMR Shareholding
13th Dec 20241:23 pmRNSResult of General Meeting
9th Dec 20247:00 amRNSBlock Listing Six Monthly Return
6th Dec 20246:30 pmRNSNotice of AGM
29th Nov 20247:00 amRNSGlass Lewis and ISS recommendations
28th Nov 20243:23 pmRNSDirector/PDMR Shareholding
28th Nov 20241:25 pmRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNS2024 Annual Report
20th Nov 20247:00 amRNSPreliminary Results
15th Nov 202411:00 amRNSPosting of Circular and Notice of General Meeting
30th Oct 20247:01 amRNSCompletion of Buyback Programme
30th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Oct 20247:00 amRNSReceipt of General Meeting Requisition Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.